Literature DB >> 16237888

Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment.

Jobst Eggerath1, Helen English, Jonathan W Leichter.   

Abstract

"Gingival enlargement" is the term now used to describe medication-related gingival overgrowth or gingival hyperplasia (AAP, 2004), a condition commonly induced by three main classes of drugs: anticonvulsants, antihypertensive calcium antagonists and the immunosuppressant cyclosporin. It is important that the health practitioner is aware of the potential aetiologic agents and characteristic features in order to be able to accurately diagnose and successfully manage patients who present with a condition such as outlined in the following case presentation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16237888

Source DB:  PubMed          Journal:  J N Z Soc Periodontol        ISSN: 0111-1485


  3 in total

Review 1.  Oral manifestation in inflammatory bowel disease: a review.

Authors:  Kamran B Lankarani; Gholam Reza Sivandzadeh; Shima Hassanpour
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

2.  Necrotizing Ulcerative Gingivitis, a Rare Manifestation as a Sequel of Drug-Induced Gingival Overgrowth: A Case Report.

Authors:  Marah Damdoum; Sudhir Rama Varma; Mohamed A Jaber; Manjusha Nambiar
Journal:  Case Rep Dent       Date:  2021-09-21

3.  Gene polymorphism in amlodipine induced gingival hyperplasia: a case report.

Authors:  Nsc Charles; V Ramesh; Kennedy Spk Babu; B Premalatha
Journal:  J Young Pharm       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.